Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nova Capital International is a boutique investment banking and corporate finance advisory firm focused on equity and debt financing for private and publicly held micro-cap companies. Publicly available descriptions characterize the firm as serving a range of sectors including financial services, fintech, biotech, biopharma, energy, natural resources, and real estate, rather than operating as a drug developer or healthcare company. Based on the available evidence, it appears to provide advisory and capital-raising services rather than developing therapeutics, diagnostics, or healthcare products. Accordingly, Nova Capital International is not a life science or biotech operating company, even though it may advise clients in biotech and biopharma.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nova Capital International.